Table 1. Total costs, available funding and funding gaps in the Global Plan to Stop TB 2006–2015, as compared with the first Global Plan, 2001–2005.
| Global Plan to Stop TB
(10-year plan)a |
First Global Plan
(5-year plan) |
||||
|---|---|---|---|---|---|
| Costs | Available funding | Funding gap | Costs | ||
| Total implementation | 47.2 | 22.5 | 24.7 | 8.0 | |
| Country costs | 44.3 | 21.8b | 22.5 | – | |
| DOTS expansion | 28.9 | – | – | 6.0 | |
| Strategy for multidrug-resistant tuberculosis | 5.8 | – | – | 1.1 | |
| TB/HIV collaborative activities | 6.7 | – | – | 0.6 | |
| Advocacy, communication and social mobilization programmes | 2.9 | – | – | 0.0 | |
| International agencies (technical cooperation)c | 2.9 | 0.7 | 2.2 | 0.3 | |
| Total new tools | 9.0 | 2.8 | 6.1 | 0.9 | |
| Vaccinesd | 3.6 | 2.1 | 1.5 | 0.4 | |
| Drugs | 4.8 | 0.6 | 4.2 | 0.3 | |
| Diagnostics |
0.5 |
0.1 |
0.4 |
0.2 |
|
| Total costs | 56.2 | 25.3 | 30.8 | 9.1 | |
a All amounts shown in billions of US$. Column totals may not add up exactly due to rounding. b The figures for domestic funding assume that governments’ commitments in 2005 are sustained and increase in line with inflation; commitments from the Global Fund to Fight AIDS, Tuberculosis and Malaria are based on results. c Technical cooperation includes strategic and technical support, capacity building, monitoring and evaluation, operational research, policy development and working groups. d This category includes costs for maintenance of the current BCG (bacille Calmette–Guérin) vaccination programme.